AR047154A1 - Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol - Google Patents

Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol

Info

Publication number
AR047154A1
AR047154A1 ARP040104752A ARP040104752A AR047154A1 AR 047154 A1 AR047154 A1 AR 047154A1 AR P040104752 A ARP040104752 A AR P040104752A AR P040104752 A ARP040104752 A AR P040104752A AR 047154 A1 AR047154 A1 AR 047154A1
Authority
AR
Argentina
Prior art keywords
insomnia
treatment
gaboxadol
administrandoles
daily amount
Prior art date
Application number
ARP040104752A
Other languages
English (en)
Spanish (es)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR047154(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR047154A1 publication Critical patent/AR047154A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
ARP040104752A 2003-12-18 2004-12-17 Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol AR047154A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200301877 2003-12-18

Publications (1)

Publication Number Publication Date
AR047154A1 true AR047154A1 (es) 2006-01-11

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104752A AR047154A1 (es) 2003-12-18 2004-12-17 Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol

Country Status (17)

Country Link
EP (1) EP1720547A1 (ja)
JP (1) JP2007515415A (ja)
KR (1) KR20060103335A (ja)
CN (1) CN1893942A (ja)
AR (1) AR047154A1 (ja)
AU (1) AU2004298313A1 (ja)
BR (1) BRPI0415893A (ja)
CA (1) CA2550610A1 (ja)
EA (1) EA200600989A1 (ja)
IL (1) IL176239A0 (ja)
IS (1) IS8390A (ja)
MX (1) MXPA06006685A (ja)
NO (1) NO20063320L (ja)
SG (1) SG133601A1 (ja)
TW (1) TW200528098A (ja)
WO (1) WO2005058313A1 (ja)
ZA (1) ZA200602762B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP1906953A4 (en) * 2005-04-29 2009-05-20 Lundbeck & Co As H FORMS OF ACID SALTS AND BASIC SALTS OF GABOXADOL
WO2019055369A1 (en) * 2017-09-12 2019-03-21 Ovid Therapeutics Inc. USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSIA
MX2021003302A (es) 2018-09-20 2021-05-13 Ovid Therapeutics Inc Uso de gaboxadol para el tratamiento del sindrome de tourette, los tics y la tartamudez.
KR20210105387A (ko) 2018-12-17 2021-08-26 오비드 테라퓨틱스 인크. 비-24 시간 수면-각성 장애의 치료를 위한 가복사돌의 사용
AU2020405060A1 (en) 2019-12-18 2022-06-09 Ovid Therapeutics Inc. Gaboxadol for therapeutic treatment of 1p36 deletion syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
CA2447603A1 (en) * 2001-05-21 2002-11-28 H. Lundbeck A/S Granular preparations of gaboxadol

Also Published As

Publication number Publication date
JP2007515415A (ja) 2007-06-14
ZA200602762B (en) 2007-06-27
TW200528098A (en) 2005-09-01
KR20060103335A (ko) 2006-09-28
BRPI0415893A (pt) 2007-01-09
EA200600989A1 (ru) 2006-10-27
MXPA06006685A (es) 2006-08-23
NO20063320L (no) 2006-07-18
SG133601A1 (en) 2007-07-30
CA2550610A1 (en) 2005-06-30
IL176239A0 (en) 2006-10-05
WO2005058313A1 (en) 2005-06-30
CN1893942A (zh) 2007-01-10
EP1720547A1 (en) 2006-11-15
AU2004298313A1 (en) 2005-06-30
IS8390A (is) 2006-03-30

Similar Documents

Publication Publication Date Title
CY1116727T1 (el) Θεραπεια πολλαπλης σκληρυνσης me laquinimod
NO20055880L (no) Memantin orale doseringsformer
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
AR050418A1 (es) Dosificacion fija de anticuerpos her
PE20170302A1 (es) Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington
AR065580A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
ECSP045069A (es) Uso de flibanserina en el tratamiento de trastornos sexuales
JP2006501240A5 (ja)
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
CO6150188A2 (es) Uso de teencteplasa para tratar un ictus isquemico agudo
AR090885A1 (es) Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple
AR054249A1 (es) Tratamiento de enfermedades del tejido conectivo de la piel
AR065581A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
AR043259A1 (es) Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello
AR065582A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR065139A1 (es) Medicamento para el tratamiento de la endometriosis
AR047154A1 (es) Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol
AR027394A1 (es) Uso de mirtazapina para el tratamiento de trastornos del sueno
ECSP066836A (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
DK1675611T3 (da) Terapeutiske anvendelser for C-peptid
NZ597675A (en) Medicament for the long term nsaid use
MX2010006310A (es) O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor.
AR061046A1 (es) Mirtazapina para el tratamiento del dolor neuropatico

Legal Events

Date Code Title Description
FA Abandonment or withdrawal